Papillomavirus E7 Proteins < Papillomavirus Infections < Papillomavirus Vaccines

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Papillomavirus Infections

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000015 (2020)	Bendikt Kramer [Allemagne] ; Angela Schell [Allemagne] ; Christoph Aderhold [Allemagne] ; Lena Huber [Allemagne] ; C Emika Mueller [Allemagne] ; Nicole Rotter [Allemagne] ; Richard Birk [Allemagne]	Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
000330 (2019)	Boya Zhang [République populaire de Chine] ; Yinjing Song [République populaire de Chine] ; Siyuan Sun [République populaire de Chine] ; Rui Han [République populaire de Chine] ; Chunting Hua [République populaire de Chine] ; Stijn Van Der Veen [République populaire de Chine] ; Hao Cheng [République populaire de Chine]	Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.
000412 (2018)	N. Mazanowska [Pologne] ; M. Szpota Ska-Sikorska [Pologne] ; A. Madej [Pologne] ; J. Pazik [Pologne] ; M. Wielgo [Pologne] ; B. Pietrzak [Pologne]	Prevalence of Cervical Infection With Human Papillomavirus of High Oncogenic Potential in Immunosuppressed Women on Renal Replacement Therapy With and Without Mammalian Target of Rapamycin Inhibitors.
000489 (2018)	Sebastian Zi Ba [Pologne] ; Artur Kowalik [Pologne] ; Kamil Zalewski [Pologne] ; Natalia Rusetska [Pologne] ; Krzysztof Goryca [Pologne] ; Agata Pia Cik [Pologne] ; Marcin Misiek [Pologne] ; Elwira Bakuła-Zalewska [Pologne] ; Janusz Kopczy Ski [Pologne] ; Kamil Kowalski [Pologne] ; Jakub Radziszewski [Pologne] ; Mariusz Bidzi Ski [Pologne] ; Stanisław G D [Pologne] ; Magdalena Kowalewska [Pologne]	Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
000593 (2018)	Tatiana Rabachini [Brésil] ; Enrique Boccardo [Brésil] ; Rubiana Andrade [Brésil] ; Katia Regina Perez [Brésil] ; Suely Nonogaki [Brésil] ; Iolanda Midea Cuccovia [Brésil] ; Luisa Lina Villa [Brésil]	HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
000606 (2018)	Andrew P. Zammit [Australie] ; Rohit Sinha [Australie] ; Caroline L. Cooper [Australie] ; Christopher F L. Perry [Australie] ; Ian H. Frazer [Australie] ; Zewen K. Tuong [Australie]	Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study.
000699 (2017)	Dominik Horn [Allemagne] ; Christian Freudlsperger [Allemagne] ; Dana Holzinger [Allemagne] ; Kevin Kunzmann [Allemagne] ; Peter Plinkert [Allemagne] ; Gerhard Dyckhoff [Allemagne] ; Jürgen Hoffmann [Allemagne] ; Kolja Freier [Allemagne] ; Jochen Hess [Allemagne]	Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
000946 (2016)	Derek Hirschman [États-Unis] ; Joselin Tacastacas [États-Unis] ; Peter L. Rady [États-Unis] ; Stephen K. Tyring [États-Unis] ; Kevin Cooper [États-Unis] ; Kord Honda [États-Unis]	Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child--A Case Report.
000958 (2016)	Juan Luis Callejas-Valera ; Ramiro Iglesias-Bartolome [États-Unis] ; Panomwat Amornphimoltham ; Julia Palacios-Garcia ; Daniel Martin [États-Unis] ; Joseph A. Califano ; Alfredo A. Molinolo ; J Silvio Gutkind	mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
000959 (2016)	Joseph D. Coppock [États-Unis] ; Paola D. Vermeer [États-Unis] ; Daniel W. Vermeer [États-Unis] ; Kimberly M. Lee [États-Unis] ; W Keith Miskimins [États-Unis] ; William C. Spanos [États-Unis] ; John H. Lee [États-Unis]	mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.
000A09 (2016)	Ingmar Blümcke [Canada] ; Harvey B. Sarnat	Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy.
000B91 (2015)	Lifang Zhang [République populaire de Chine] ; Jianhong Wu [Australie, République populaire de Chine] ; Ming Tat Ling [Australie] ; Liang Zhao [Australie] ; Kong-Nan Zhao [République populaire de Chine, Australie]	The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
000C20 (2015)	Jiezhong Chen [Australie]	Signaling pathways in HPV-associated cancers and therapeutic implications.
000C55 (2015)	Roland Coras [Allemagne] ; Klaus Korn ; Christian G. Bien ; Thilo Kalbhenn ; Karl Rössler ; Katja Kobow ; Johannes Giedl ; Bernhard Fleckenstein ; Ingmar Blumcke	No evidence for human papillomavirus infection in focal cortical dysplasia IIb.
000D59 (2015)	Konrad Klinghammer [Allemagne] ; Jan-Dirk Raguse ; Thomas Plath ; Andreas E. Albers ; Korinna Joehrens ; Andre Zakarneh ; Bernadette Brzezicha ; Annika Wulf-Goldenberg ; Ulrich Keilholz ; Jens Hoffmann ; Iduna Fichtner	A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
000E36 (2014)	Kate Connolly [Australie] ; Pete Manders ; Peter Earls ; Richard J. Epstein	Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
000E65 (2014)	Alcides Chaux [Paraguay] ; Enrico Munari ; Antonio L. Cubilla ; Jessica Hicks ; Kristen Lecksell ; Arthur L. Burnett ; George J. Netto	Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases.
000F64 (2013)	Jennifer M. Spangle [États-Unis] ; Karl Munger	The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species.
001037 (2013)	Joseph D. Coppock [États-Unis] ; Bryant G. Wieking ; Alfredo A. Molinolo ; J Silvio Gutkind ; W Keith Miskimins ; John H. Lee	Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
001069 (2013)	Zurab Surviladze [États-Unis] ; Rosa T. Sterk ; Sergio A. Deharo ; Michelle A. Ozbun	Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.
001081 (2013)	Sayaka Ueno [Japon] ; Tamotsu Sudo ; Noriko Oka ; Senn Wakahashi ; Satoshi Yamaguchi ; Kiyoshi Fujiwara ; Yoshiki Mikami ; Ryuichiro Nishimura	Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Papillomavirus Infections" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Papillomavirus Infections" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Papillomavirus Infections
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020